更正 "在随机 III 期试验 FIRE-3 (AIO KRK-0306) 中，早期体重减轻是接受一线治疗的转移性结直肠癌患者生存期缩短和副作用增加的独立风险因素"

IF 5.7 2区医学 Q1 ONCOLOGY

International Journal of Cancer Pub Date : 2024-09-18 DOI:10.1002/ijc.35186

{"title":"更正 \"在随机 III 期试验 FIRE-3 (AIO KRK-0306) 中，早期体重减轻是接受一线治疗的转移性结直肠癌患者生存期缩短和副作用增加的独立风险因素\"","authors":"","doi":"10.1002/ijc.35186","DOIUrl":null,"url":null,"abstract":"\n Liu, L, Erickson, NT, Ricard, I, et al. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306). Int J Cancer. 2022; 150(1): 112-123. doi:10.1002/ijc.33775\n Hana Algül's affiliation was provided incorrectly and should have been “Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.”We apologize for this error.","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":"156 1","pages":"E1"},"PeriodicalIF":5.7000,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijc.35186","citationCount":"0","resultStr":"{\"title\":\"Correction to “Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)”\",\"authors\":\"\",\"doi\":\"10.1002/ijc.35186\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Liu, L, Erickson, NT, Ricard, I, et al. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306). Int J Cancer. 2022; 150(1): 112-123. doi:10.1002/ijc.33775\\n Hana Algül's affiliation was provided incorrectly and should have been “Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.”We apologize for this error.\",\"PeriodicalId\":180,\"journal\":{\"name\":\"International Journal of Cancer\",\"volume\":\"156 1\",\"pages\":\"E1\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2024-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ijc.35186\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ijc.35186\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ijc.35186","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

Liu, L, Erickson, NT, Ricard, I, et al. 在随机 III 期试验 FIRE-3 (AIO KRK-0306) 中，早期体重减轻是导致接受一线治疗的转移性结直肠癌患者生存期缩短和副作用增加的独立风险因素。Int J Cancer. 2022; 150(1):112-123. doi:10.1002/ijc.33775 Hana Algül的工作单位有误，应为 "Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany. "我们对此错误深表歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to “Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306)”

Liu, L, Erickson, NT, Ricard, I, et al. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306). Int J Cancer. 2022; 150(1): 112-123. doi:10.1002/ijc.33775

Hana Algül's affiliation was provided incorrectly and should have been “Comprehensive Cancer Center München, Chair for Tumor Metabolism, Klinikum rechts der Isar, Technical University of Munich, School of Medicine and Health, Munich, Bavaria, Germany.”

We apologize for this error.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

International Journal of Cancer 医学-肿瘤学

CiteScore

13.40

自引率

3.10%

发文量

460

审稿时长

2 months

期刊介绍： The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention